EC committees lock horns on risk assessments for medicines

Moves to establish the first environmental risk assessment requirements for pharmaceuticals have prompted a disagreement between two EC expert committees. Proposals drawn up by the European medicines agency have been criticised by the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) for paying little attention to chronic toxicity risks to aquatic organisms and disregarding established approaches to risk assessment and toxicity testing.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content



Prices on request

  • Full access to for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits